These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4795227)

  • 21. Intra-arterial adriamycin chemotherapy for bladder cancer. Semiselective intra-arterial chemotherapy with compression of the femoral arteries at the time of injection.
    Uyama T; Moriwaki S; Yonezawa M; Fujita J
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S59-63. PubMed ID: 6640836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of 5-fluorouracil, pirarubicin and low-dose consecutive administration of cisplatin for advanced and recurrent gastric cancer.
    Kikuyama S; Inada T; Miyakita M; Ogata Y
    Jpn J Clin Oncol; 1998 May; 28(5):314-7. PubMed ID: 9703858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intra-arterial infusion chemotherapy with [Sar1, Ile8] angiotensin II in bladder cancer].
    Morita T; Kikuchi T; Hara Y; Ishikawa S; Kobayashi Y; Ishiyama S; Tozuka K; Goto K; Nakashima N; Takahashi K
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3417-22. PubMed ID: 2802636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients].
    Chernyĭ VA
    Vopr Onkol; 1970 Apr; 16(4):61-4. PubMed ID: 4989339
    [No Abstract]   [Full Text] [Related]  

  • 26. Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system.
    Lokich J; Bothe A; Zipoli T; Green R; Sonneborn H; Paul S; Philips D
    J Clin Oncol; 1983 Jan; 1(1):24-8. PubMed ID: 6668481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adriamycin in advanced bronchogenic carcinoma.
    Cortes EP; Takita H; Holland JF
    Cancer; 1974 Sep; 34(3):518-25. PubMed ID: 4368383
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of long-term, continuous-infusion doxorubicin.
    Garnick MB; Weiss GR; Steele GD; Israel M; Schade D; Sack MJ; Frei E
    Cancer Treat Rep; 1983 Feb; 67(2):133-42. PubMed ID: 6825120
    [No Abstract]   [Full Text] [Related]  

  • 29. [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].
    Wakui A; Yokoyama M; Konno K; Nakai Y; Sakano T; Koyama Y; Imamura Y; Nakajima O; Niijima T; Akaza H
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):118-24. PubMed ID: 3966806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study.
    Gottlieb JA; Rivkin SE; Spigel SC; Hoogstraten B; O'Bryan RM; Delaney FC; Singhakowinta A
    Cancer; 1974 Feb; 33(2):519-26. PubMed ID: 4812769
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract.
    Martino S; Samal B; Al-Sarraf M
    Cancer Treat Rep; 1980 Jan; 64(1):161-3. PubMed ID: 7379051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
    Stephens RL; Hoogstraten B
    Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):517-9. PubMed ID: 7195306
    [No Abstract]   [Full Text] [Related]  

  • 34. [Phase II study of epirubicin on breast cancer: a cooperative group study].
    Tominaga T; Kitamura M; Nomura Y; Abe O; Enomoto K; Ikeda T; Izuo M; Iino Y; Taguchi T; Tamura K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2187-92. PubMed ID: 3459397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical trial of adriamycin in the malignant lymphomas.
    Cimo PL; Rudders RA; Hensleigh D
    Cancer; 1974 Nov; 34(5):1571-5. PubMed ID: 4609593
    [No Abstract]   [Full Text] [Related]  

  • 36. Intraarterial infusion of 4'-O-tetrahydropyranyl-adriamycin for head and neck tumors.
    Honda T; Ohyama W; Sonoda T; Uchida K; Hirokawa T; Takada K; Takeda C
    Jpn J Antibiot; 1984 Jun; 37(6):959-65. PubMed ID: 6492386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
    Saito T; Kasai Y; Wakui A; Furue H; Majima H; Nitani H; Niijima T; Takeda C; Abe O; Koyama Y
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
    Hill GJ; Grage TB; Wilson W; Ansfield FJ
    J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
    [No Abstract]   [Full Text] [Related]  

  • 39. [Polycardiographic evaluation of the cardiotoxicity of adriamycin].
    Villani F; Beretta G; Guindani A; Pagnoni A; Vivarelli S
    G Ital Chemioter; 1975; 22(1-2):39-46. PubMed ID: 1235351
    [No Abstract]   [Full Text] [Related]  

  • 40. A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin.
    Garnick MB; Ensminger WD; Israel M
    Cancer Res; 1979 Oct; 39(10):4105-10. PubMed ID: 476647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.